A clinical study based on a Mexican population also indicated that Annexin II is meaningful for both APS clinical diagnosis and mechanistic research, as the positive rate of anti-Annexin II antibodies in the serum of APS and SLE patients was significantly higher than that in healthy individuals and patients without thrombosis (60). The gene discussed is ANXA2; the disease is deep vein thrombosis.